Chapter 77 – Brain metastases†

作者: Jaime Gállego Pérez-Larraya , Jerzy Hildebrand

DOI: 10.1016/B978-0-7020-4088-7.00077-8

关键词:

摘要: Brain metastases are the most frequent neurological complication of cancer and common brain tumour type. Lung breast cancers, melanoma responsible for up to three-quarters metastatic lesions. Most patients exhibit either headache, seizures, focal deficits, cognitive or gait disorders, which severely impair quality life. best demonstrated by MRI, is sensitive but non-specific. The main differential diagnosis includes primary tumours, abscesses, vascular inflammatory Overall prognosis poor depends on age, extent activity systemic disease, number performance status. In about half patients, especially those with widespread uncontrolled malignancy, death heavily related extra-neural lesions, treatment cerebral disease doesn’t significantly improve survival. such aim stabilize deficit maintain Corticosteroids whole-brain radiotherapy usually fulfill this purpose. By contrast, limited metastases, good status controlled may benefit from aggressive as both life survival primarily Several efficacious therapeutic options including surgery, chemotherapy available these patients.

参考文章(104)
J B Posner, N L Chernik, Intracranial metastases from systemic cancer Advances in Neurology. ,vol. 19, pp. 579- 592 ,(1978)
Roberta Rudà, Marzia Borgognone, Franco Benech, Ezio Vasario, Riccardo Soffietti, Brain metastases from unknown primary tumour: a prospective study. Journal of Neurology. ,vol. 248, pp. 394- 398 ,(2001) , 10.1007/S004150170180
Sabine Urbanits, Stefan Oberndorfer, Heinz Lahrmann, Thomas Schmal, Wolfgang Grisold, Klaus Lindner, [The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna]. Wiener Klinische Wochenschrift. ,vol. 114, pp. 911- 916 ,(2002)
Peter D. Schellinger, Hans M. Meinck, Armin Thron, Diagnostic accuracy of MRI compared to CCT in patients with brain metastases Journal of Neuro-oncology. ,vol. 44, pp. 275- 281 ,(1999) , 10.1023/A:1006308808769
Nicolas Massager, György T. Szeifert, Françoise De Smedt, Isabelle Salmon, Philippe David, Daniel DeVriendt, Jacques Brotchi, Marc Levivier, Sandrine Rorive, Observations of intracranial neoplasms treated with gamma knife radiosurgery Journal of Neurosurgery. ,vol. 97, pp. 623- 626 ,(2002) , 10.3171/JNS.2002.97.SUPPLEMENT
G Sze, Y Kawamura, C Johnson, R Lange, R J Wolf, S N Goldberg, R J Friedland, Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. American Journal of Neuroradiology. ,vol. 19, pp. 821- 828 ,(1998)
Pieter E. Postmus, Hanny Haaxma-Reiche, Egbert F. Smit, Harry J. M. Groen, Hanna Karnicka, Tadeusz Lewinski, Jan van Meerbeeck, Mario Clerico, Anna Gregor, Desmond Curran, Tarek Sahmoud, Anne Kirkpatrick, Giuseppe Giaccone, Treatment of Brain Metastases of Small-Cell Lung Cancer: Comparing Teniposide and Teniposide With Whole-Brain Radiotherapy—A Phase III Study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group Journal of Clinical Oncology. ,vol. 18, pp. 3400- 3408 ,(2000) , 10.1200/JCO.2000.18.19.3400
M Forsting, M Knauth, S Heiland, M Hartmann, T Balzer, K Sartor, MR enhancement of brain lesions: increased contrast dose compared with magnetization transfer. American Journal of Neuroradiology. ,vol. 17, pp. 1853- 1859 ,(1996)
Bernd Echtenacher, Daniela N. Männel, Michael Hafner, Bernhard Nieswandt, Lysis of Tumor Cells by Natural Killer Cells in Mice Is Impeded by Platelets Cancer Research. ,vol. 59, pp. 1295- 1300 ,(1999)
Magid H. Amer, Muhyi Al-Sarraf, Laurence H. Baker, Vainutis K. Vaitkevicius, Malignant melanoma and central nervous system metastases.Incidence, diagnosis, treatment and survival Cancer. ,vol. 42, pp. 660- 668 ,(1978) , 10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E